Key result
Existing EV-D68 models remain valuable for evaluating vaccines and therapeutics despite imperfectly replicating human disease.
Why the study?
Existing in vitro and in vivo experimental models may not fully recapitulate both respiratory and neurological disease observed in human EV-D68 infection.
This review summarizes current in vitro and in vivo models for EV-D68 infection, highlighting their utility and limitations in understanding pathogenesis and developing countermeasures.
Models aid EV-D68 countermeasure development despite incomplete human recapitulation; leaves open need for improved systems capturing respiratory and neurological features.
Enterovirus D68 (EV-D68) is one of hundreds of non-polio enteroviruses that typically cause cold-like respiratory illness. The first EV-D68 outbreak in the United States in 2014 aroused widespread concern among the public and health authorities. The infection was found to be associated with increased surveillance of acute flaccid myelitis, a neurological condition that causes limb paralysis in conjunction with spinal cord inflammation. In vitro studies utilising two-dimensional (2D) and three-dimensional (3D) culture systems have been employed to elucidate the pathogenic mechanism of EV-D68. Various animal models have also been developed to investigate viral tropism and distribution, pathogenesis, and immune responses during EV-D68 infection. EV-D68 infections have primarily been investigated in respiratory, intestinal and neural cell lines/tissues, as well as in small-size immunocompetent rodent models that were limited to a young age. Some studies have implemented strategies to overcome the barriers by using immunodeficient mice or virus adaptation. Although the existing models may not fully recapitulate both respiratory and neurological disease observed in human EV-D68 infection, they have been valuable for studying pathogenesis and evaluating potential vaccine or therapeutic candidates. In this review, we summarise the methodologies and findings from each experimental model and discuss their applications and limitations.
No takes yet. Share an insight, caveat, or question.
Hooi et al. (2023) conducted a review in Enterovirus D68 (EV-D68) infection. In vitro and in vivo models was evaluated. Existing in vitro and in vivo models are valuable for studying EV-D68 pathogenesis and evaluating potential vaccine or therapeutic candidates, despite not fully recapitulating human disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: